The Associated Press September 7, 2010, 6:02PM ET

Watson Pharma gets approval for generic Yasmin

Watson Pharmaceuticals Inc. said Tuesday it received marketing approval for a generic version of Bayer's oral contraceptive Yasmin.

Watson said it has started shipping the drug under the brand name Zarah after getting clearance from the Food and Drug Administration. Bayer is suing Watson for patent infringement.

Watson said sales of Yasmin and its other generic equivalents totaled $97 million over the year ended June 30, according to IMS Health data.


BW Mall - Sponsored Links

Buy a link now!